Physician profile
Michelle Cantrell
NPI 1407060320
$2,798.11
in general payments reported to CMS, 2019-2025
17 companies · $566 in 2025
The $566 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $22.54 · 2021: $23.68 · 2022: $139 · 2023: $904 · 2024: $381 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $490.20 | 2022-2025 | Miebo, Xiidra, Infuse |
| Glaukos Corporation | $409.68 | 2021-2024 | Photrexa Cross-Linking Kit, Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Lkc Technologies, INC. | $293.90 | 2023-2025 | |
| Rxsight INC | $270.33 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $255.10 | 2023-2024 | Acuvue |
| Carl Zeiss Meditec, INC. | $210.91 | 2019 | |
| Omeros Corporation | $124.51 | 2019 | |
| Aerie Pharmaceuticals, INC. | $124.07 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $120.83 | 2019 | |
| Abbvie INC. | $118.00 | 2023 | Durysta |
| Tarsus Pharmaceuticals, INC. | $112.91 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.55 | 2019 | |
| Optos, INC. | $96.35 | 2019-2022 | |
| Allergan, INC. | $22.54 | 2020 | |
| Coopervision INC. | $19.28 | 2023 | Myday Contact Lens |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $16.84 | 2025 | Iyuzeh |
| Alcon Vision LLC | $13.11 | 2023 | Total30 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Cantrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.